Tumour-Treg-Targeting is a collaborative research and training platform established to provide innovative and comprehensive training in antibody-based drug design to next-generation scientists in academia and industry in order to enable them to develop the next generation of antibody-based biologicals targeting and shifting the immunological environment specifically within tumours.
The project is funded by the Marie-Sklodowska-Curie Innovative Training Network within the Horizon 2020 Programme…
via https://ift.tt/1puljGF
No comments:
Post a Comment